Adherence to tamoxifen over the five-year course

Breast Cancer Research and Treatment

Volumn 99, Issue 2, 2006, Pages 215-220

  Lash, Timothy L ^a,b   Fox, Matthew P ^a,b   Westrup, Jennifer L ^b   Fink, Aliza K ^c   Silliman, Rebecca A ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ORC Macro   (United States)

Author keywords

Adherence; Breast cancer; Tamoxifen

Indexed keywords

TAMOXIFEN;

AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER SURGERY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INFORMATION PROCESSING; INTERVIEW; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL RECORD; PATIENT COMPLIANCE; PATIENT INFORMATION; PREDICTOR VARIABLE; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT WITHDRAWAL; UNSPECIFIED SIDE EFFECT;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; ATTITUDE TO HEALTH; BREAST NEOPLASMS; FEMALE; HEALTH CARE SURVEYS; HUMANS; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT EDUCATION AS TOPIC; RISK FACTORS; TAMOXIFEN; TIME FACTORS;

EID: 33747594260     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-006-9193-0     Document Type: Article

References (26)

1. Early Breast Cancer Trialists' Collaborative Group Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Lancet 365: 1687-1717, 2005
2. Lash TL, Silliman RA.: Re: Prevalence of cancer. Letter to the editor. J Natl Cancer Inst 90: 399-400, 1998
3. Powles T, Eeles R, Ashley S, Easton D, Chang J, Dowsett M, Tidy A, Viggers J, Davey J.: Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet 352: 98-101, 1998
4. Fink AK, Gurwitz J, Rakowski W, Guadagnoli E, Silliman RA.: Patient beliefs and tamoxifen continuance in older women with estrogen receptor-positive breast cancer. J Clin Oncol 22: 3309-3315, 2004
5. Haynes RB, McDonald HP, Garg AX.: Helping patients follow prescribed treatment: clinical applications. JAMA 288: 2880-2883, 2002
6. Jackevicius CA, Mamdani M, Tu JV.: Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 288: 462-467, 2002
7. Demissie S, Silliman RA, Lash TL.: Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women. J Clin Oncol 19: 322-328, 2001
8. Partridge AH, Wang PS, Winer EP, Avorn J.: Non-adherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol 21: 602-606, 2003
9. van Servellen G, Chang B, Garcia L, Lombardi E.: Individual and system level factors associated with treatment non-adherence in human immunodeficiency virus-infected men and women. AIDS Patient Care STDS 16: 269-281, 2002
10. Balkrishnan R.: Predictors of medication adherence in the elderly. Clin Ther 20: 764-771, 1998
11. Grunfeld EA, Hunter MS, Sikka P, Mittal S.: Adherence beliefs among breast cancer patients taking tamoxifen. Patient Educ Couns 59: 97-102, 2005
12. Silliman RA, Guadagnoli E, Rakowski W, Landrum MB, Lash TL, Wolf R, Fink A, Ganz PA, Gurwitz J, Borbas C, Mor V.: Adjuvant tamoxifen prescription in women 65 years and older with early stage breast cancer. J Clin Oncol 20: 2680-2688, 2002
13. Fleming ID.: AJCC Cancer Staging Manual. (5th edn.). Lippincott Williams & Wilkins, Philadelphia, 1997
14. Ware J.: SF-36 Health Survey, Manual and Interpretation Guide. The Health Institute, Boston, 1993
15. Coscarelli-Schag CA, Ganz PA, Heinrich RL.: Cancer rehabilitation evaluation system - short form (CARES-SF): a cancerspecific rehabilitation and quality of life instrument. Cancer 68: 1406-1413, 1991
16. Day R, Ganz PA, Costantino JP, Cronin WM, Wickerham DL, Fisher B.: Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Clin Oncol 17: 2659-2669, 1999
17. Fisher B, Costantino J, Redmond C, Poisson R, Bowman D, Couture J, Dimitrov NV, Wolmark N, Wickerham DL, Fisher ER.: A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 320: 479-484, 1989
18. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N.: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90: 1371-1388, 1998
19. Winer EP, Hudis C, Burstein HJ, Wolff AC, Pritchard KI, Ingle JN, Chlebowski RT, Gelber R, Edge SB, Gralow J, Cobleigh MA, Mamounas EP, Goldstein LJ, Whelan TJ, Powles TJ, Bryant J, Perkins C, Perotti J, Braun S, Langer AS, Browman GP, Somerfield MR.: American society of clinical oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for post-menopausal women with hormone-receptor-positive breast cancer: status report 2004. J Clin Oncol 23: 619-629, 2005
20. Prochaska JO, Velicer WF, Rossi JS, Goldstein MG, Marcus BH, Rakowski W, Fiore C, Harlow LL, Redding CA, Rosenbloom D.: Stages of change and decisional balance for 12 problem behaviors. Health Psychol 13: 39-46, 1994
21. Janis IL, Mann L.: Psychological Analysis of Conflict, Choice, and Commitment. Macmillan, London, 1977
22. Horne R, Weinman J.: Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 47: 555-567, 1999
23. Ruggiero L.: Transtheoretical model: applications in the prevention and treatment of cancer. Med Pediatr Oncol 1: 69-74, 1998
24. Rakowski W, Andersen MR, Stoddard AM, Urban N, Rimer BK, Lane DS, Fox SA, Costanza ME.: Confirmatory analysis of opinions regarding the pros and cons of mammography. Health Psychol 16: 433-441, 1997
25. Osterberg L, Blaschke T.: Adherence to medication. N Engl J Med 353: 487-497, 2005
26. Garber MC, Nau DP, Erickson SR.: The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care 42: 649-652, 2004